Microbiome-Based Products: Therapeutic Potential for Inflammatory Skin Diseases
International Journal of Molecular Sciences · 14.07.2025 · 26 (14) · 6745
DOI: 10.3390/ijms26146745 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2025. Verfasst von Anamarija Rušanac und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intercellular Communication, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Šalata 2, 10000 …. Hauptthemen laut MEDLINE: Microbiota, Skin Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, ERDF.
Abstract (Originalsprache)
Maintaining a balanced skin microbiota is essential for skin health, whereas disruptions in skin microbiota composition, known as dysbiosis, can contribute to the onset and progression of various skin disorders. Microbiota dysbiosis has been associated with several inflammatory skin conditions, including atopic dermatitis, seborrheic dermatitis, acne, psoriasis, and rosacea. Recent advances in high-throughput sequencing and metagenomic analyses have provided a deeper understanding of the skin microbial communities in both health and disease. These discoveries are now being translated into novel therapeutic approaches aimed at restoring microbial balance and promoting skin health through microbiome-based interventions. Unlike conventional therapies that often disrupt the microbiota and lead to side effects or resistance, microbiome-based products offer a more targeted strategy for preventing and managing inflammatory skin diseases. These products, which include probiotics, prebiotics, postbiotics, and live biotherapeutic agents, are designed to modulate the skin ecosystem by enhancing beneficial microbial populations, suppressing pathogenic strains, and enhancing immune tolerance. As a result, they represent a promising class of products with the potential to prevent, manage, and even reverse inflammatory skin conditions. However, realizing the full therapeutic potential of microbiome-based strategies in dermatology will require continued research, robust clinical validation, and clear regulatory frameworks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intercellular Communication, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Šalata 2, 10000 Zagreb, Croatia.
- BIMIS-Biomedical Research Center Šalata, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
ORCID-Profile: Mario Matijašić, Hana Čipčić Paljetak, Mihaela Perić
Förderung
- European Regional Development Fund
- ERDF
Zitieren
APA
Rušanac, A., Škibola, Z., Matijašić, M., Čipčić Paljetak, H., & Perić, M. (2025). Microbiome-Based Products: Therapeutic Potential for Inflammatory Skin Diseases. International Journal of Molecular Sciences, 26(14), 6745. https://doi.org/10.3390/ijms26146745
Vancouver
Rušanac A, Škibola Z, Matijašić M, Čipčić Paljetak H, Perić M. Microbiome-Based Products: Therapeutic Potential for Inflammatory Skin Diseases. International Journal of Molecular Sciences. 2025;26(14):6745. doi:10.3390/ijms26146745
BibTeX
@article{Ruanac2025,
author = {Rušanac, Anamarija and Škibola, Zara and Matijašić, Mario and Čipčić Paljetak, Hana and Perić, Mihaela},
title = {Microbiome-Based Products: Therapeutic Potential for Inflammatory Skin Diseases},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {14},
pages = {6745},
doi = {10.3390/ijms26146745}
}
EUVIMED